Effect of bupivacaine lozenges on oral mucositis pain: a randomized controlled multicenter phase II study

摘要

Introduction:A nonblinded parallel-group randomized controlled study investigated the efficacy and tolerability of repeated administration of a bupivacaine lozenge (25 mg) as pain management for oral mucositis pain in head and neck cancer patients as add-on to standard systemic pain management.